Subcutaneous Infliximab and Assumptions of Response in Ileal Crohn's Disease: Does Route of Administration Matter? Chetwood JD, Little RD. Clin Gastroenterol Hepatol 2026 Mar 5:S1542-3565(26)00151.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chetwood JD, Little RD. Subcutaneous Infliximab and Assumptions of Response in Ileal Crohn's Disease: Does Route of Administration Matter? Clin Gastroenterol Hepatol 2026 Mar 5:S1542-3565(26)00151.
PMID: 41794213